25I-NBOH
Aliases: Cimbi-27, Nboh-2c-i, nboh-2ci
Summary
25I-NBOH is approximately 2-3 times less potent than 25I-NBOMe but significantly more potent than 2C-I. Not orally active; must be administered sublingually or buccally. Extreme vasoconstriction and cardiovascular strain reported at higher doses.
Perspectives
“I canβt really see any permanent psychedelic therapy uses for this one, as while it does fill the user with beautiful colorful empathy while it lasts, it eventually fades to the exact same state as before. I can say though, it had the most beautiful and intense visuals of any trip.”
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Sublingual | 200-500Β΅g | 500-900Β΅g | 900-1400Β΅g | 1400Β΅g+ |
| Buccal | 200-500Β΅g | 500-900Β΅g | 900-1400Β΅g | 1400Β΅g+ |
| Oral | 416ug-766 | 800-1400Β΅g | 1400ug-2000 | 2000Β΅g+ |
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | Total |
|---|---|---|---|---|---|
| Sublingual | 15-60 min | 30-90 min | 2-3.5 hrs | 1.5-2.5 hrs | 5-10 hrs |
| Buccal | 15-60 min | 30-90 min | 2-3.5 hrs | 1.5-2.5 hrs | 4.2-8.5 hrs |
| Oral | 19-45 min | 30-90 min | 2-3.5 hrs | 1.5-2.5 hrs | 5-10 hrs |
Effect Profile
12 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong visuals, auditory effects, body load, and headspace
Strong anxiety/jitters with moderate euphoria, mild stimulation and focus
Tolerance
Tolerance Decay
Rapid within-session tolerance typical of serotonergic psychedelics; redosing adds side effects with limited benefit. Return to baseline generally reported within 1β3 weeks.
Cross-Tolerances
Effects
Aggregated from 12 Erowid experience reports